- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05096975
Personality Profile of Children and Adolescents With ADHD and With or Without Emotional Dysregulation
Comparative Study of the Personality Profile of Children and Adolescents With Attention Deficit Hyperactive Disorder (ADHD) With or Without Emotional Dysregulation
Attention Deficit Hyperactivity Disorder (ADHD) is frequently associated with emotional dysregulation (ED). ED is characterized by excessive and inappropriate emotional reactions compared to social norms, uncontrolled and rapide shifts in emotion and attention focused on emotional stimuli.
According to research, there are strong correlations between personality traits and psychiatric disorder as ADHD. In a longitudinal study, the persistence of ADHD symptoms during adolescence is associated with high neuroticism, low agreeableness and low conscience. Studies show that these personality traits are factors of vulnerabilities for comordities associated with ADHD and are predictive of overall functioning difficulties. Studies show correlations between ADHD in childhood and personality disorders at adulthood .
ADHD is frequently associated with emotional dysregulation (ED) that is characterized by an inability to modulate emotional responses in a given context . ED is observed in 24% to 50% children with ADHD . Children with ADHD and ED are more likely to present a severe and complex symptomatology and are at risk for antisocial and bordeline personality disorders than children without ED. To date, there would be no studies which would have been interested in personality traits in children with ADHD and ED.
The main objective is to determine if children with ADHD and ED present from childhood traits of personality as low agreeableness, low conscience and high neuroticism that are predictive of personality disorders at adulthood. It would involve earl identification of children at increased risk of pejorative developmental trajectories.
The second objectives are:
- Improve understanding of the heterogeneity of ADHD symptom expression;
- Have a better understanding of the child's personalit and temperament traits to identify riks and protective factors;
- Identify children with ADHD with profiles at risk of personality disorders in order to adapt the care according to the child's needs.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Uhmontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- Children with a diagnostic of ADHD and followed at Montpellier University Hospital.
- Children and adolescents aged between 7 and 12 years.
Description
Inclusion criteria:
- Children and adolescents aged 7-12 years followed at Montpellier University Hospital ;
- Children and adolescents with a diagnostic of ADHD (diagnostics criteria from DSM-V);
- Children and adolescents benefiting from a multidisciplinary evaluation or therapeutic group at the child psychiatry unit of Montpellier University Hospital
Exclusion criteria:
- Family non-french speaking
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Control group
ADHD without emotion dysregulation (Control group) The group is composed of children with ADHD and with a score ≤ 180 at the CBCL-A-A-A when combining the "Aggressive behaviors", "Anxiety/Depression" and "Attention" subscales.
|
The intervention involves the completion of two questionnaires by parents at child psychiatry unit of Montpellier University Hospital when children come to participate in a psychometric assessment or when parents or children participate in therapeutic group. All parents completed Child Behavior Checklist (CBCL; Achenbach & Rescorla, 2001), a 118-item questionnaire to measure emotional and behavior problems in 4 to 18-years-old children in the past six months and Hierarchical Personality Inventory for Children (HiPIC, Mervielde & De Fruyt, 1999, a 144-item questionnaire to obtain a profile of the personality of 6 to 12-year-old children. |
Deficit Emotion Self Regulation group
ADHD without moderate emotion dysregulation (Deficit Emotion Self Regulation group) The group is composed of children with ADHD and with a score ≥180 and ≤ 210 at the CBCL-A-A-A when combining the "Aggressive behaviors", "Anxiety/Depression" and "Attention" subscales.
|
The intervention involves the completion of two questionnaires by parents at child psychiatry unit of Montpellier University Hospital when children come to participate in a psychometric assessment or when parents or children participate in therapeutic group. All parents completed Child Behavior Checklist (CBCL; Achenbach & Rescorla, 2001), a 118-item questionnaire to measure emotional and behavior problems in 4 to 18-years-old children in the past six months and Hierarchical Personality Inventory for Children (HiPIC, Mervielde & De Fruyt, 1999, a 144-item questionnaire to obtain a profile of the personality of 6 to 12-year-old children. |
Dysregulation Profile Group
ADHD with severe emotion dysregulation (Dysregulation Profile Group) The group is composed of children with ADHD and with a score ≥ 210 at the CBCL-A-A-A when combining the "Aggressive behaviors", "Anxiety/Depression" and "Attention" subscales.
|
The intervention involves the completion of two questionnaires by parents at child psychiatry unit of Montpellier University Hospital when children come to participate in a psychometric assessment or when parents or children participate in therapeutic group. All parents completed Child Behavior Checklist (CBCL; Achenbach & Rescorla, 2001), a 118-item questionnaire to measure emotional and behavior problems in 4 to 18-years-old children in the past six months and Hierarchical Personality Inventory for Children (HiPIC, Mervielde & De Fruyt, 1999, a 144-item questionnaire to obtain a profile of the personality of 6 to 12-year-old children. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Score at the CBCL-A-A-A
Time Frame: 1 day
|
Score at the CBCL-A-A-A when combining the "Aggressive behaviors", "Anxiety/Depression" and "Attention" subscales (Achenbach & Rescorla, 2001). Questionnaire measures emotional and behavior problem in 4 to 18 year-old children in the past months. |
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of Score of Hierachical Personality Inventory for Childen
Time Frame: 1 day
|
Score of Hierachical Personality Inventory for Childen (HiPIC, Mervielde & De Fruyt, 1999), 144-item questionnaire to obtain a profile of the personality Questionnaire obtains a profile of personality of 6 to 12 year-old children. |
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Romo, PHD, University Paris Nanterre
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL20_0524
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
University of PennsylvaniaNational Institutes of Health (NIH)TerminatedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Working MemoryUnited States
-
National Institute on Alcohol Abuse and Alcoholism...TerminatedAttention Deficit Disorder | Attention Deficit Hyerpactivity DisorderUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Sheba Medical CenterWithdrawnAttention Deficit Disorder With Hyperactivity | Attention-Deficit Disorder in Adolescence
-
Soroka University Medical CenterUnknownAttention Deficit Disorder PatientsIsrael
-
Tel-Aviv Sourasky Medical CenterElMindA Ltd; Brainsway; Ornim Medical Ltd.UnknownAdult Attention Deficit DisorderIsrael
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity Disorder | Attention Deficit DisorderUnited States
Clinical Trials on Evaluation of the CBCL-A-A-A and HiPIC in children with ADHD and with ED or without ED
-
Ohio State UniversityWithdrawnCognitive Impairment | Physical DisabilityUnited States
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
Johns Hopkins Bloomberg School of Public HealthMedifast, Inc.Completed
-
University Hospital, Clermont-FerrandUnknownPostpartum Depression | Postpartum Hemorrhage | Postpartum Women | Postpartum Stress | Postpartum AnxietyFrance
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)CompletedOpioid-use DisorderUnited States
-
Lena ReuterskioldRecruitingAnxiety Depression | CBTSweden
-
Institut National de la Santé Et de la Recherche...UNITAIDUnknownTuberculosis | Severe Acute MalnutritionZambia, Uganda
-
Rennes University HospitalINRIA, Hybrid team; Ecole Centrale Nantes, laboratoire Ambiances, Architectures...CompletedAlzheimer or Mild Cognitive ImpairmentFrance
-
Hunter College of City University of New YorkRecruiting
-
University of BolognaAzienda Ospedaliera Universitaria Policlinico Paolo GiacconeNot yet recruitingCancer Related Cardiovascular ToxicityItaly, North Macedonia, Serbia